Please provide your email address to receive an email when new articles are posted on . Patients improved visual acuity across three concentrations of pilocarpine. Adverse events were mild and ...

The Companies plan to file an application with the FDA in the second half of 2025. Topline data were announced from a phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) for the ...

Scientists have developed new eye drops that could help with presbyopia. Ekaterina Vasileva-Bagler/Getty Images For this study, researchers recruited 766 participants diagnosed with presbyopia.

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Yuvezzi is available at retail pharmacies or directly to patients through PHIL, an all-in-one digital hub and ...

There were 26 serious adverse events in 19 participants; 21 (81%) occurred within 2 months after surgery. HealthDay News — In participants with geographic atrophy due to age-related macular ...

In this China Phase 3 safety and efficacy trial, LNZ100 (1.75% aceclidine HCl) achieved the primary endpoint and key secondary endpoints, with statistically significant three-lines or greater ...

Treating and preventing correctable vision impairments could prevent up to 19% of dementia prevalence, according to a new study. Dementia prevention strategies should involve going over risk factors ...